Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Names NCGR Certified Service Provider

NEW YORK (GenomeWeb News) – Agilent Technologies today announced the National Center for Genome Resources as a Certified Service Provider for the company's SureSelect Target Enrichment System for next-generation sequencing.

NCGR, based in Santa Fe, NM, now provides Agilent exome and custom target enrichment services along with sequencing and analysis for genomics research. The facility offers sequencing services on Illumina and Pacific Biosciences platforms. Its services, as well as collaborations it has, cover cancer, infectious diseases, inherited childhood diseases, legume biology, crop improvement, and population genetics.

"Achieving CSP status is an important step, allowing us to expand our sequencing menu to offer enrichment of genomic regions in conjunction with next-gen sequencing, a service for which there is growing demand," Callum Bell, NCGR's vice president for research, said in a statement.

NCGR participated in comprehensive on-site training and passed a set of requirements demonstrating expertise and skill in order to attain CSP status, said Agilent.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.